Return-Path: <admin@aspireindia.co.in>
Delivered-To: govancoz+spam@zacp120.webway.host
Received: from zacp120.webway.host
	by zacp120.webway.host with LMTP
	id cINpKvRK1Wjs7QAA8rC0kQ
	(envelope-from <admin@aspireindia.co.in>)
	for <govancoz+spam@zacp120.webway.host>; Thu, 25 Sep 2025 16:00:20 +0200
Return-path: <admin@aspireindia.co.in>
Envelope-to: cheryl@govan.co.za
Delivery-date: Thu, 25 Sep 2025 16:00:20 +0200
Received: from vps.aviwebhosting.com ([103.154.184.57]:39402)
	by zacp120.webway.host with esmtps  (TLS1.3) tls TLS_AES_256_GCM_SHA384
	(Exim 4.98.2)
	(envelope-from <admin@aspireindia.co.in>)
	id 1v1mWA-00000000hj4-2RcU
	for cheryl@govan.co.za;
	Thu, 25 Sep 2025 16:00:20 +0200
Received: from ws-dip-gc02.diplomat.com.mt (c155-179.i01-7.onvol.net [212.56.155.179])
	by vps.aviwebhosting.com (Postfix) with ESMTPA id BC0911A8A34E;
	Tue, 23 Sep 2025 18:40:48 +0530 (IST)
DKIM-Signature: v=1; a=rsa-sha256; c=relaxed/simple; d=aspireindia.co.in;
	s=default; t=1758633057;
	bh=AWHbQmNnamkvqAhu22zIrTQHr7WiItCBHCK/75sYkmM=;
	h=Subject:To:From:Date:Reply-To;
	b=P+ovaTOIjE3EHV6AvfHh6o5PVPPFlOkYWcc64N+/Iww7jaqvRHdOvQ5b9eXl25T68
	 nSuhR/PUWzQbYwarGZqukK4pRDi8iUpbZG05GLaWVoF/sHs/RDsvC8GjUVqdC6c/Zi
	 RFKh255v5YiQgwYTHZllzWGe07L/TVjKXDPIK1pA=
Content-Type: multipart/alternative; boundary="===============1663509991=="
MIME-Version: 1.0
To: Recipients <admin@aspireindia.co.in>
From: "Dr. Shingo Iwamoto" <admin@aspireindia.co.in>
Date: Tue, 23 Sep 2025 15:10:22 +0200
Reply-To: drshingoiwamotopharm1@gmail.com
X-Spam-Status: Yes, score=9.4
X-Spam-Score: 94
X-Spam-Bar: +++++++++
X-Spam-Report: =?ISO-8859-1?Q?Spam_detection_software=2C_running_on_the_system_=22zacp120=2Ewebway?= =?ISO-8859-1?Q?=2Ehost=22=2C=0A_has_identified_this_incoming_email_a?= =?ISO-8859-1?Q?s_possible_spam=2E__The_original=0A_message_has_been_?= =?ISO-8859-1?Q?attached_to_this_so_you_can_view_it_or_label=0A_simil?= =?ISO-8859-1?Q?ar_future_email=2E__If_you_have_any_questions=2C_see=0A_?= =?ISO-8859-1?Q?root=5C=40localhost_for_details=2E=0A_Content_preview?= =?ISO-8859-1?Q?=3A__Dear_Esteemed_Professional=2C_I_hope_this_messag?= =?ISO-8859-1?Q?e_finds_you=0A___well=2E_Nichi-Iko_Pharmaceutical_Co=2E=2C?= =?ISO-8859-1?Q?_Ltd=2E=2C_a_leading_pharmaceutical_manufacturer=0A__?= =?ISO-8859-1?Q?__based_in_Japan=2C_is_currently_seeking_a_qualified_?= =?ISO-8859-1?Q?individual_to_=5B=2E=2E=2E=5D_=0A_Content_analysis_de?= =?ISO-8859-1?Q?tails=3A___=289=2E4_points=2C_5=2E0_required=29=0A__p?= =?ISO-8859-1?Q?ts_rule_name______________description=0A_----_-------?= =?ISO-8859-1?Q?---------------_-------------------------------------?= =?ISO-8859-1?Q?-------------=0A__0=2E1_URIBL=5FCSS=5FA____________Co?= =?ISO-8859-1?Q?ntains_URL's_A_record_listed_in_the_Spamhaus_CSS=0A__?= =?ISO-8859-1?Q?___________________________blocklist=0A______________?= =?ISO-8859-1?Q?_______________=5BURI=3A_aspireindia=2Eco=2Ein/103=2E1?= =?ISO-8859-1?Q?54=2E184=2E57=5D=0A__0=2E0_URIBL=5FBLOCKED__________A?= =?ISO-8859-1?Q?DMINISTRATOR_NOTICE=3A_The_query_to_URIBL_was_blocked?= =?ISO-8859-1?Q?=2E=0A_____________________________See=0A____________?= =?ISO-8859-1?Q?_________________http=3A//wiki=2Eapache=2Eorg/spamass?= =?ISO-8859-1?Q?assin/DnsBlocklists#dnsbl-block=0A___________________?= =?ISO-8859-1?Q?___________for_more_information=2E=0A________________?= =?ISO-8859-1?Q?_____________=5BURI=3A_aspireindia=2Eco=2Ein=5D=0A__4?= =?ISO-8859-1?Q?=2E5_URIBL=5FDBL=5FSPAM_________Contains_a_spam_URL_l?= =?ISO-8859-1?Q?isted_in_the_Spamhaus_DBL=0A_________________________?= =?ISO-8859-1?Q?____blocklist=0A_____________________________=5BURI=3A_?= =?ISO-8859-1?Q?aspireindia=2Eco=2Ein=5D=0A_-0=2E0_SPF=5FPASS________?= =?ISO-8859-1?Q?_______SPF=3A_sender_matches_SPF_record=0A_-0=2E1_DKI?= =?ISO-8859-1?Q?M=5FVALID=5FAU__________Message_has_a_valid_DKIM_or_D?= =?ISO-8859-1?Q?K_signature_from_author's=0A_________________________?= =?ISO-8859-1?Q?____domain=0A_-0=2E1_DKIM=5FVALID_____________Message?= =?ISO-8859-1?Q?_has_at_least_one_valid_DKIM_or_DK_signature=0A__0=2E1?= =?ISO-8859-1?Q?_DKIM=5FSIGNED____________Message_has_a_DKIM_or_DK_si?= =?ISO-8859-1?Q?gnature=2C_not_necessarily_valid=0A_-0=2E1_DKIM=5FVAL?= =?ISO-8859-1?Q?ID=5FEF__________Message_has_a_valid_DKIM_or_DK_signa?= =?ISO-8859-1?Q?ture_from=0A_____________________________envelope-fro?= =?ISO-8859-1?Q?m_domain=0A__0=2E2_FREEMAIL=5FREPLYTO=5FEND=5FDIGIT_R?= =?ISO-8859-1?Q?eply-To_freemail_username_ends_in_digit=0A___________?= =?ISO-8859-1?Q?__________________=5Bdrshingoiwamotopharm1=28at=29gma?= =?ISO-8859-1?Q?il=2Ecom=5D=0A__0=2E0_RCVD=5FIN=5FVALIDITY=5FCERTIFIE?= =?ISO-8859-1?Q?D=5FBLOCKED_RBL=3A_ADMINISTRATOR_NOTICE=3A_The=0A____?= =?ISO-8859-1?Q?_________________________query_to_Validity_was_blocke?= =?ISO-8859-1?Q?d=2E__See=0A_____________________________https=3A//kn?= =?ISO-8859-1?Q?owledge=2Evalidity=2Ecom/hc/en-us/articles/2096173068?= =?ISO-8859-1?Q?1243=0A______________________________for_more_informa?= =?ISO-8859-1?Q?tion=2E=0A_________________________=5B103=2E154=2E184?= =?ISO-8859-1?Q?=2E57_listed_in_sa-trusted=2Ebondedsender=2Eorg=5D=0A?= =?ISO-8859-1?Q?__0=2E0_RCVD=5FIN=5FVALIDITY=5FRPBL=5FBLOCKED_RBL=3A_?= =?ISO-8859-1?Q?ADMINISTRATOR_NOTICE=3A_The_query_to=0A______________?= =?ISO-8859-1?Q?________________Validity_was_blocked=2E__See=0A______?= =?ISO-8859-1?Q?_______________________https=3A//knowledge=2Evalidity?= =?ISO-8859-1?Q?=2Ecom/hc/en-us/articles/20961730681243=0A___________?= =?ISO-8859-1?Q?___________________for_more_information=2E=0A________?= =?ISO-8859-1?Q?____________________=5B103=2E154=2E184=2E57_listed_in?= =?ISO-8859-1?Q?_bl=2Escore=2Esenderscore=2Ecom=5D=0A__0=2E0_RCVD=5FI?= =?ISO-8859-1?Q?N=5FVALIDITY=5FSAFE=5FBLOCKED_RBL=3A_ADMINISTRATOR_NO?= =?ISO-8859-1?Q?TICE=3A_The_query_to=0A______________________________?= =?ISO-8859-1?Q?Validity_was_blocked=2E__See=0A______________________?= =?ISO-8859-1?Q?_______https=3A//knowledge=2Evalidity=2Ecom/hc/en-us/?= =?ISO-8859-1?Q?articles/20961730681243=0A___________________________?= =?ISO-8859-1?Q?___for_more_information=2E=0A________________________?= =?ISO-8859-1?Q?_____=5B103=2E154=2E184=2E57_listed_in_sa-accredit=2Eh?= =?ISO-8859-1?Q?abeas=2Ecom=5D=0A__0=2E0_HTML=5FMESSAGE___________BOD?= =?ISO-8859-1?Q?Y=3A_HTML_included_in_message=0A__3=2E0_KAM=5FSA=5FZA?= =?ISO-8859-1?Q?=5FABUSE________2TLD_Providers_prevalent_in_spam_abus?= =?ISO-8859-1?Q?e=0A__1=2E8_FREEMAIL=5FFORGED=5FREPLYTO_Freemail_in_R?= =?ISO-8859-1?Q?eply-To=2C_but_not_From?=
X-Spam-Flag: YES
Subject:  ***SPAM***  Proposal for Strategic Business Collaboration.

You will not see this in a MIME-aware mail reader.
--===============1663509991==
Content-Type: text/plain; charset="iso-8859-1"
MIME-Version: 1.0
Content-Transfer-Encoding: quoted-printable
Content-Description: Mail message body

Dear Esteemed Professional,
 I hope this message finds you well.
 Nichi-Iko Pharmaceutical Co., Ltd., a leading pharmaceutical manufacturer =
based in Japan, is currently seeking a qualified individual to serve as our=
 official representative in South Africa. This role involves managing miner=
al procurement and overseeing the establishment of our annex office in Sout=
h Africa under a five-year contractual agreement.
 This is a strategic opportunity to represent a respected global brand and =
play a key role in expanding our international presence. We are offering a =
competitive compensation package along with decision-making autonomy.
 If you are interested in learning more, kindly respond to this message for=
 further details.
 Warm regards,
Dr. Shingo Iwamoto
President & CEO
Nichi-Iko Pharmaceutical Co., Ltd.
5-4 Nihonbashi-Honcho 1-chome, Chuo-ku, Tokyo, Japan

--===============1663509991==
Content-Type: text/html; charset="iso-8859-1"
MIME-Version: 1.0
Content-Transfer-Encoding: quoted-printable
Content-Description: Mail message body

<HTML><head><meta http-equiv=3D"Content-Type" content=3D"text/html; charset=
=3Diso-8859-1"/></head><BODY><P>Dear Esteemed Professional,</P>
<P>I hope this message finds you well.</P>
<P>Nichi-Iko Pharmaceutical Co., Ltd., a leading pharmaceutical manufacture=
r based in Japan, is currently seeking a qualified individual to serve as o=
ur official representative in South Africa. This role involves managing min=
eral procurement and overseeing the establishment of our annex office in So=
uth Africa under a five-year contractual agreement.</P>
<P>This is a strategic opportunity to represent a respected global brand an=
d play a key role in expanding our international presence. We are offering =
a competitive compensation package along with decision-making autonomy.</P>
<P>If you are interested in learning more, kindly respond to this message f=
or further details.</P>
<P>Warm regards,<BR>Dr. Shingo Iwamoto<BR>President &amp; CEO<BR>Nichi-Iko =
Pharmaceutical Co., Ltd.<BR>5-4 Nihonbashi-Honcho 1-chome, Chuo-ku, Tokyo, =
Japan</P></BODY></HTML>
--===============1663509991==--